In silico screening and experimental validation identify riboflavin as an RNA-targeted antiviral against SARS-CoV-2. - Jeong, Chae-Hong; Na, Yoo Jin; Kim, Tae Yong; Lee, So Young; Kim, Jungyeon; Ryou, Sangmi (Scientific Reports, 2025)